Zalcberg J - Search Results

1

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.

Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, Holloway AJ. Tothill RW, et al. Among authors: zalcberg j. Cancer Res. 2005 May 15;65(10):4031-40. doi: 10.1158/0008-5472.CAN-04-3617. Cancer Res. 2005. PMID: 15899792

2

The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.

Parisot JP, Hu XF, Sutherland RL, Wakeling A, Zalcberg JR, DeLuise M. Parisot JP, et al. Among authors: zalcberg jr. Int J Cancer. 1995 Aug 9;62(4):480-4. doi: 10.1002/ijc.2910620420. Int J Cancer. 1995. PMID: 7635575

3

Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.

Hu XF, Veroni M, De Luise M, Wakeling A, Sutherland R, Watts CK, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Int J Cancer. 1993 Nov 11;55(5):873-6. doi: 10.1002/ijc.2910550529. Int J Cancer. 1993. PMID: 8244585

4

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.

Parisot JP, Hu XF, DeLuise M, Zalcberg JR. Parisot JP, et al. Among authors: zalcberg jr. Br J Cancer. 1999 Feb;79(5-6):693-700. doi: 10.1038/sj.bjc.6690112. Br J Cancer. 1999. PMID: 10070856 Free PMC article.

5

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.

Hu XF, Slater A, Rischin D, Kantharidis P, Parkin JD, Zalcberg J. Hu XF, et al. Among authors: zalcberg j. Br J Cancer. 1999 Feb;79(5-6):831-7. doi: 10.1038/sj.bjc.6690133. Br J Cancer. 1999. PMID: 10070877 Free PMC article.

6

Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.

Hu XF, Slater A, Kantharidis P, Rischin D, Juneja S, Rossi R, Lee G, Parkin JD, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Blood. 1999 Jun 15;93(12):4086-95. Blood. 1999. PMID: 10361105 Free article.

7

Does biomodulation of 5-fluorouracil improve results?

Sobrero AF, Herrmann R, Rischin D, Zalcberg J. Sobrero AF, et al. Among authors: zalcberg j. Eur J Cancer. 1999 Feb;35(2):186-94. doi: 10.1016/s0959-8049(98)00362-1. Eur J Cancer. 1999. PMID: 10448257 Review. No abstract available.

8

Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.

Parisot JP, Leeding KS, Hu XF, DeLuise M, Zalcberg JR, Bach LA. Parisot JP, et al. Among authors: zalcberg jr. Breast Cancer Res Treat. 1999 Jun;55(3):231-42. doi: 10.1023/a:1006274712664. Breast Cancer Res Treat. 1999. PMID: 10517168

9

A phase I trial of docetaxel and gemcitabine in patients with advanced cancer.

Rischin D, Boyer M, Smith J, Millward M, Michael M, Bishop J, Zalcberg J, Davison J, Emmett E, McClure B. Rischin D, et al. Among authors: zalcberg j. Ann Oncol. 2000 Apr;11(4):421-6. doi: 10.1023/a:1008384326701. Ann Oncol. 2000. PMID: 10847460 Free article. Clinical Trial.

10

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.

Rischin D, Ackland SP, Smith J, Garg MB, Clarke S, Millward MJ, Toner GC, Zalcberg J. Rischin D, et al. Among authors: zalcberg j. Ann Oncol. 2002 Nov;13(11):1810-8. doi: 10.1093/annonc/mdf305. Ann Oncol. 2002. PMID: 12419756 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page